ID Q8T9N3_PLAFA Unreviewed; 616 AA. AC Q8T9N3; Q8MM01; DT 01-JUN-2002, integrated into UniProtKB/TrEMBL. DT 01-JUN-2002, sequence version 1. DT 24-JAN-2024, entry version 53. DE SubName: Full=BAEBL protein {ECO:0000313|EMBL:AAM45251.1}; DE SubName: Full=Erythrocyte binding antigen region II {ECO:0000313|EMBL:CAD27555.1}; DE SubName: Full=Erythrocyte binding protein-2 {ECO:0000313|EMBL:AAK55484.1}; DE Flags: Fragment; GN Name=EBP2 {ECO:0000313|EMBL:AAK55484.1}; GN Synonyms=eba-140 {ECO:0000313|EMBL:CAD27555.1}; OS Plasmodium falciparum (malaria parasite P. falciparum). OC Eukaryota; Sar; Alveolata; Apicomplexa; Aconoidasida; Haemosporida; OC Plasmodiidae; Plasmodium; Plasmodium (Laverania). OX NCBI_TaxID=5833 {ECO:0000313|EMBL:AAK55484.1}; RN [1] {ECO:0000313|EMBL:AAK55484.1} RP NUCLEOTIDE SEQUENCE. RC STRAIN=3D7 {ECO:0000313|EMBL:AAK55484.1}; RX PubMed=11814568; DOI=10.1016/S0166-6851(01)00428-5; RA Narum D.L., Fuhrmann S.R., Luu T., Sim B.K.; RT "A novel Plasmodium falciparum erythrocyte binding protein-2 (EBP2/BAEBL) RT involved in erythrocyte receptor binding."; RL Mol. Biochem. Parasitol. 119:159-168(2002). RN [2] {ECO:0000313|EMBL:AAM45251.1} RP NUCLEOTIDE SEQUENCE. RA Mayer D.G., Mu J.-B., Feng X., Su X.-Z., Miller L.H.; RT "Polymorphisms in Plasmodium falciparum Erythrocyte-Binding Ligand Change RT its Receptor Specificity."; RL Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases. RN [3] {ECO:0000313|EMBL:CAD27555.1} RP NUCLEOTIDE SEQUENCE. RX PubMed=12702678; RA Baum J., Thomas A.W., Conway D.J.; RT "Evidence for diversifying selection on erythrocyte-binding antigens of RT Plasmodium falciparum and P. vivax."; RL Genetics 163:1327-1336(2003). CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AH010777; AAK55484.1; -; Genomic_DNA. DR EMBL; AF507986; AAM45251.1; -; Genomic_DNA. DR EMBL; AF507987; AAM45252.1; -; Genomic_DNA. DR EMBL; AF507988; AAM45253.1; -; Genomic_DNA. DR EMBL; AJ438830; CAD27555.1; -; Genomic_DNA. DR EMBL; AJ438831; CAD27556.1; -; Genomic_DNA. DR EMBL; AJ438837; CAD27562.1; -; Genomic_DNA. DR EMBL; AJ438838; CAD27563.1; -; Genomic_DNA. DR EMBL; AJ438842; CAD27567.1; -; Genomic_DNA. DR EMBL; AJ438844; CAD27569.1; -; Genomic_DNA. DR EMBL; AJ438845; CAD27570.1; -; Genomic_DNA. DR EMBL; AJ438846; CAD27571.1; -; Genomic_DNA. DR EMBL; AJ438848; CAD27573.1; -; Genomic_DNA. DR EMBL; AJ438851; CAD27576.1; -; Genomic_DNA. DR EMBL; AJ438852; CAD27577.1; -; Genomic_DNA. DR EMBL; AJ438853; CAD27578.1; -; Genomic_DNA. DR AlphaFoldDB; Q8T9N3; -. DR VEuPathDB; PlasmoDB:PF3D7_1301600; -. DR VEuPathDB; PlasmoDB:PfCD01_130006500; -. DR VEuPathDB; PlasmoDB:PfGB4_130007100; -. DR VEuPathDB; PlasmoDB:PfGN01_130007700; -. DR VEuPathDB; PlasmoDB:PfKE01_130006800; -. DR VEuPathDB; PlasmoDB:PfNF166_130006800; -. DR VEuPathDB; PlasmoDB:PfNF54_130006700; -. DR VEuPathDB; PlasmoDB:PfSN01_000019200; -. DR VEuPathDB; PlasmoDB:PfTG01_130006900; -. DR GO; GO:0016020; C:membrane; IEA:InterPro. DR GO; GO:0046789; F:host cell surface receptor binding; IEA:InterPro. DR Gene3D; 1.10.287.1660; -; 1. DR Gene3D; 1.20.58.830; -; 2. DR Gene3D; 1.20.1310.20; Duffy-antigen binding domain; 2. DR InterPro; IPR042202; Duffy-ag-bd_sf. DR InterPro; IPR008602; Duffy-antigen-binding. DR Pfam; PF05424; Duffy_binding; 2. DR SUPFAM; SSF140924; Duffy binding domain-like; 2. PE 4: Predicted; FT DOMAIN 34..204 FT /note="Duffy-antigen binding" FT /evidence="ECO:0000259|Pfam:PF05424" FT DOMAIN 338..508 FT /note="Duffy-antigen binding" FT /evidence="ECO:0000259|Pfam:PF05424" FT NON_TER 1 FT /evidence="ECO:0000313|EMBL:AAK55484.1" FT NON_TER 616 FT /evidence="ECO:0000313|EMBL:AAK55484.1" SQ SEQUENCE 616 AA; 73498 MW; D89A89BAB4ADF94C CRC64; QYTFIQKRTH LFACGIKRKS IKWICRENSE KITVCVPDRK IQLCIANFLN SRLETMEKFK EIFLISVNTE AKLLYNKNEG KDPSIFCNEL RNSFSDFRNS FIGDDMDFGG NTDRVKGYIN KKFSDYYKEK NVEKLNNIKK EWWEKNKANL WNHMIVNHKG NISKECAIIP AEEPQINLWI KEWNENFLME KKRLFLNIKD KCVENKKYEA CFGGCRLPCS SYTSFMKKSK TQMEVLTNLY KKKNSGVDKN NFLNDLFKKN NKNDLDDFFK NEKEYDDLCD CRYTATIIKS FLNGPAKNDV DIASQINVND LRGFGCNYKS NNEKSWNCTG TFTNKFPGTC EPPRRQTLCL GRTYLLHRGH EEDYKEHLLG ASIYEAQLLK YKYKEKDENA LCSIIQNSYA DLADIIKGSD IIKDYYGKKM EENLNKVNKD KKRNEESLKI FREKWWDENK ENVWKVMSAV LKNKETCKDY DKFQKIPQFL RWFKEWGDDF CEKRKEKIYS FESFKVECKK KDCDENTCKN KCSEYKKWID LKKSEYEKQV DKYTKDKNKK MYDNIDEVKN KEANVYLKEK SKECKDVNFD DKIFNESPNE YEDMCKKCDE IKYLNEIKYP KTKHDI //